Firefly Inks Latest Commercial Agreement for Use of its FDA-Cleared BNA™ Platform in Groundbreaking Precision Neuroscience Research

– Institute of Human Genetics at Heidelberg University Hospital ongoing EEG biomarker study on 15q13.3 CNVs –

– Collaboration aims to uncover novel insights into the brain’s functional architecture in rare genetic conditions –

Read more at globenewswire.com